Lexicon Pharmaceuticals | LXRX - Eps Gewinn Pro Aktie

Aktienkurs
2.34
Täglich Wechseln
0.34 16.75%
Monatlich
32.67%
Jährlich
233.10%
Q2 Prognose
1.96




Eps Veränderung Datum
Abbott USD 1.15 0.35 2026-03
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
Akebia Therapeutics USD -0.04 0.04 2025-12
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
AstraZeneca USD 2.58 0.46 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Esperion Therapeutics USD 0.26 0.42 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
Illumina USD 1.15 0.2 2026-03
Insmed USD -0.76 0.78 2026-03
Ironwood Pharmaceuticals USD 0.24 0.25 2026-03
J&J USD 2.7 0.24 2026-03
Lexicon Pharmaceuticals USD -0.04 0.01 2025-12
MacroGenics USD -0.22 0.49 2025-12
MannKind USD -0.02 0.03 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Novartis USD 1.99 0.04 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Sarepta Therapeutics USD 3.16 6.74 2026-03
Thermo Fisher Scientific USD 5.44 1.13 2026-03
Ultragenyx Pharmaceutical USD -1.84 0.55 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vanda Pharmaceuticals USD -0.09 0 2024-12